약물 서방 방출형 다공성 수산화인회석

다국어 초록 (Multilingual Abstract)

Sustained drug release of hollow HA was investigated. HA slurry was prepared with amount of 30-70% HA(H groups) and sodium chloride up to 15%(N groups). Alginate beads were coated with HA slurry and burned out. In order to insert vancomycin-laden PLGA nanoparticles into hollow HA granules, vacuum pressure was applied. Drug release rates of vancomycin from HA/PLGA complex were monitored.
Size of HA spherical granules was controlled by injecting size or dropping speed into liquid nitrogen. Internal empty space that formed by burning out alginate beads during sintering was connected to external surface through pores in the shell. In H groups, increasing the ratio between HA and water, thickness of shell was increased, while the pore size and porosity was decreased because pores were formed as water frozen and subsequent sublimation of ice inside the shell. Addition of sodium chloride did not affect pore size and porosity in N groups. However, irregular-shaped pores were caused because sodium chloride that remains after the lyophilization burns out during the sintering. This played a role in delay the initial burst out of the drug.
In conclusion, tailoring the structure of pore channels between internal space and external surface was the key to control the sustained drug release rate.

참고문헌 (Reference)

1 Dion A, "Vancomycin release behaviour from amorphous calcium pyrophosphate matrices intended for osteomyelitis treatment" 26 : 7276-7285, 2005

2 Sharma CP, "Synthesis of biocompatible hydroxyapatite powders and granules" 7 : 8-11, 1993

3 Hench LL, "Surface-active biomaterials" 226 : 630-636, 1984

4 Misiek DJ, "Soft tissue responses to hydroxylapatite particles of different shapes" 42 : 150-160, 1984

5 German RM, "Sintering theory and practice" Wiley 1996

6 Chaim R, "Sintering and densification of nanocrystalline ceramic oxide powders : a review" 107 : 159-169, 2008

7 Nohe A, "Signal transduction of bone morphogenetic protein receptors" 16 : 291-299, 2004

8 Son JS, "Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres" 153 : 133-140, 2011

9 Karageorgiou V, "Porosity of 3D biomaterial scaffolds and osteogenesis" 26 : 5474-5491, 2005

10 Richardson TP, "Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene theraphy" 11 : 47-58, 2001

11 West JL, "Polymeric biomaterials with degradation sites for proteases involved in cell migration" 32 : 241-244, 1999

12 Mainardes RM, "PLGA nanoparticles containing praziquantel. effect of formulation variables on size distribution" 290 : 137-144, 2005

13 Dennis JE, "Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously : effect of fibronectin and laminin on cell retention and rate of osteogenic expression" 1 : 23-32, 1992

14 Christenson EM, "Nanobiomaterial applications in orthopedics" 25 : 11-22, 2007

15 Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999

16 Healy KE, "Molecular engineering of materials for bioreactivity" 4 : 381-387, 1999

17 Webster TJ, "Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin" 7 : 291-301, 2001

18 de Bruijn JD, "Initial bone matrix formation at the hydroxyapatite interface in vivo" 29 : 89-99, 1995

19 Roy DM, "Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange" 5438 : 220-222, 1974

20 Cerroni L, "Growth of osteoblast like cells on porous hydroxyapatite ceramics : an in vitro study" 19 : 119-124, 2002

21 Whitaker MJ, "Growth factor release from tissue engineering scaffolds" 53 : 1427-1437, 2001

22 Babensee JE, "Growth factor delivery for tissue engineering" 11 : 47-58, 2000

23 Kim SM, "Gelatin-layered and multi-sized porous β-tricalcium phosphate for tissue engineering scaffold" 7 : 1-5, 2012

24 Sakiyama Elbert SE, "Functional biomaterials : design of noble biomaterials" 31 : 183-201, 2001

25 Mellonig J, "Freeze-dried bone allografts in periodontal reconstructive surgery" 35 : 504-511, 1991

26 Salthouse TN, "Evaluation of biomaterials" John Wiley and Sons 295-305, 1980

27 Webster TJ, "Enhanced functions of osteoblasts on nanophase ceramics" 21 : 1803-1810, 2000

28 Boonsongrit Y, "Controlled release of bovine serum albumin from hydroxyapatite microspheres for protein delivery system" 148 : 162-165, 2008

29 Li WJ, "Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size" 12 : 1775-1785, 2006

30 Winn SR, "Carrier systems for bone morphogenetic proteins" 367 : S95-S106, 1999

31 Gittings JP, "Calcium phosphate open porous scaffold bioceramics" 17 : 284-286, 2005

32 Jarcho M., "Calcium phosphate ceramics as hard tissue prosthetics" 157 : 259-278, 1981

33 Alexander H, "CRC critical reviews" CRC Press 43-, 1987

34 Schmitt JM, "Bone morphogenetic proteins : An update on basic biology and clinical relevance" 17 : 269-278, 1999

35 Davies JE, "Bone Engineering" EM Squared 2000

36 Klein C, "Biodegradation behavior of various calcium-phosphate materials in bone tissue" 17 (17): 769-784, 1983

37 Rezwan K, "Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering" 27 : 3413-3431, 2006

38 Parsons JR, "Bioceramics:material characteristics versus in vivo behavior" The New York Academy of Sciences 191-, 1988

39 Weinlander M, "Bioceramics and the human body" Elsevier Science Publishers 317-, 1992

40 Boden SD, "Bioactive factors for bone tissue engineering" 367 : S84-S94, 1999

41 Ducheyne P, "Bioactive ceramics : the effect of surface reactivity on bone formation and bone cell function" 20 : 2287-2303, 1999

42 Hubbell JA, "Bioactive biomaterials" 10 : 123-129, 1999

43 Jose MV, "Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering" 5 : 305-315, 2009

44 Suzuki Y, "Alginate hydrogel linked with syntheic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo" 50 : 405-409, 2000

45 Quintero G, "A six months clinical evaluation of decalcified freeze-dried bone allograft in periodontal osseous defects" 53 : 726-734, 1982